Showing 1 - 14 results of 14 for search 'Auke Beishuizen', query time: 0.04s Refine Results
  1. 1
    P1069: GONADAL FUNCTION AND FERTILITY PRESERVATION IN PEDIATRIC PATIENTS WITH HODGKIN LYMPHOMA TREATED ACCORDING TO THE EURONET-PHL-C2 PROTOCOL: THE FERTILITY ADD-ON STUDY

    P1069: GONADAL FUNCTION AND FERTILITY PRESERVATION IN PEDIATRIC PATIENTS WITH HODGKIN LYMPHOMA TREATED ACCORDING TO THE EURONET-PHL-C2 PROTOCOL: THE FERTILITY ADD-ON STUDY by Katja Drechsel, Simone Broer, Auke Beishuizen, Hamish Wallace, Gertjan Kaspers, Margreet Veening

    Published 2023-08-01
    Get full text
    Article
  2. 2
    The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-Sternberg Cells in Pediatric Patients With Classical Hodgkin Lymphoma

    The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-Sternberg Cells in Pediatric Patients With Classical Hodgkin L... by Eline A. M. Zijtregtop, Eline A. M. Zijtregtop, Ilse Tromp, Rana Dandis, Christian M. Zwaan, Christian M. Zwaan, King H. Lam, Friederike A. G. Meyer-Wentrup, Auke Beishuizen, Auke Beishuizen

    Published 2022-08-01
    Get full text
    Article
  3. 3
    Plasma thymus and activation‐regulated chemokine (TARC) as diagnostic marker in pediatric Hodgkin lymphoma

    Plasma thymus and activation‐regulated chemokine (TARC) as diagnostic marker in pediatric Hodgkin lymphoma by Eline A. M. Zijtregtop, Friederike Meyer‐Wentrup, Wai‐Chu Wong, Raoull Hoogendijk, Marta Lopez‐Yurda, Christian M. Zwaan, Auke Beishuizen

    Published 2020-07-01
    Get full text
    Article
  4. 4
    Nivolumab plus Brentuximab vedotin +/- bendamustine combination therapy: a safe and effective treatment in pediatric recurrent and refractory classical Hodgkin lymphoma

    Nivolumab plus Brentuximab vedotin +/- bendamustine combination therapy: a safe and effective treatment in pediatric recurrent and refractory classical Hodgkin lymphoma by Patrick Greve, Patrick Greve, Auke Beishuizen, Melanie Hagleitner, Jan Loeffen, Margreet Veening, Marianne Boes, Marianne Boes, Victor Peperzak, Claudius Diez, Friederike Meyer-Wentrup

    Published 2023-07-01
    Get full text
    Article
  5. 5
    Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma

    Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma by Eline A. M. Zijtregtop, Iris van der Strate, Auke Beishuizen, Christian M. Zwaan, Marijn A. Scheijde-Vermeulen, Arianne M. Brandsma, Friederike Meyer-Wentrup

    Published 2021-02-01
    Get full text
    Article
  6. 6
    Machine Learning Logistic Regression Model for Early Decision Making in Referral of Children with Cervical Lymphadenopathy Suspected of Lymphoma

    Machine Learning Logistic Regression Model for Early Decision Making in Referral of Children with Cervical Lymphadenopathy Suspected of Lymphoma by Eline A. M. Zijtregtop, Louise A. Winterswijk, Tammo P. A. Beishuizen, Christian M. Zwaan, Rutger A. J. Nievelstein, Friederike A. G. Meyer-Wentrup, Auke Beishuizen

    Published 2023-02-01
    Get full text
    Article
  7. 7
    A meta-analysis on the diagnostic performance of whole-body MRI for the initial staging of Hodgkin lymphoma in children and adults using FDG-PET/CT as a reference standard

    A meta-analysis on the diagnostic performance of whole-body MRI for the initial staging of Hodgkin lymphoma in children and adults using FDG-PET/CT as a reference standard by Suzanne Spijkers, M.D., Ph.D., Annemieke S. Littooij, M.D., Ph.D., Auke Beishuizen, M.D., Ph.D., Marnix G.E.H. Lam, M.D., Ph.D., Rutger A.J. Nievelstein, M.D., Ph.D.

    Published 2023-01-01
    Get full text
    Article
  8. 8
    S215: KEYNOTE-667: OPEN-LABEL, PHASE 2 STUDY OF PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT-LINE CHEMOTHERAPY

    S215: KEYNOTE-667: OPEN-LABEL, PHASE 2 STUDY OF PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT-L... by Luciana Vinti, Stephen Daw, Constantino Sabado Alvarez, Franca Fagioli, Auke Beishuizen, Gerard Michel, Maria Luisa Moleti, Michaela Cepelova, Anne Thorwarth, Charlotte Rigaud, Diego Plaza Lopez de Sabando, Judith Landman-Parker, Juan Shen, Pallavi Pillai, Patricia Marinello, Christine Mauz-Koerholz

    Published 2023-08-01
    Get full text
    Article
  9. 9
    P089: Pembrolizumab in Pediatric and Young Adults Patients With Newly Diagnosed Classical Hodgkin Lymphoma and Slow Early Responders to Frontline Chemotherapy: The Phase 2 KEYNOTE-667 Study

    P089: Pembrolizumab in Pediatric and Young Adults Patients With Newly Diagnosed Classical Hodgkin Lymphoma and Slow Early Responders to Frontline Chemotherapy: The Phase 2 KEYNOTE-... by Luciana Vinti, Stephen Daw, Constantino Sabado Alvarez, Franca Fagioli, Auke Beishuizen, Gerard Michel, Maria Luisa Moleti, Michaela Cepelova, Anne Thorwarth, Charlotte Rigaud, Diego Plaza Lopez De Sabando, Judith Landman Parker, Ying Zhu, Pallavi Pillai, Akash Nahar, Christine Mauz-Koerholz

    Published 2022-10-01
    Get full text
    Article
  10. 10
    Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group

    Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet... by Stephen Daw, Dirk Hasenclever, Maurizio Mascarin, Ana Fernández-Teijeiro, Walentyna Balwierz, Auke Beishuizen, Roberta Burnelli, Michaela Cepelova, Alexander Claviez, Karin Dieckmann, Judith Landman-Parker, Regine Kluge, Dieter Körholz, Christine Mauz-Körholz, William Hamish Wallace, Thierry Leblanc, on behalf of the EuroNet Paediatric Hodgkin Lymphoma Group

    Published 2020-02-01
    Get full text
    Article
  11. 11
    Apparent Lack of BRAFV600E Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8+ T Cells in Langerhans Cell Histiocytosis

    Apparent Lack of BRAFV600E Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8+ T Cells in Langerhans Cell Histiocytosis by Paul G. Kemps, Timo C. Zondag, Eline C. Steenwijk, Quirine Andriessen, Jelske Borst, Sandra Vloemans, Dave L. Roelen, Lenard M. Voortman, Robert M. Verdijk, Carel J. M. van Noesel, Arjen H. G. Cleven, Cynthia Hawkins, Veronica Lang, Arnoud H. de Ru, George M. C. Janssen, Geert W. Haasnoot, Kees L. M. C. Franken, Ronald van Eijk, Nienke Solleveld-Westerink, Tom van Wezel, R. Maarten Egeler, R. Maarten Egeler, Auke Beishuizen, Auke Beishuizen, Jan A. M. van Laar, Oussama Abla, Cor van den Bos, Cor van den Bos, Peter A. van Veelen, Astrid G. S. van Halteren, Astrid G. S. van Halteren

    Published 2020-01-01
    Get full text
    Article
  12. 12
    Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary Involvement

    Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary Involvement by Emma Kroeze, Laura Arias Padilla, Max Bakker, Judith M. Boer, Melanie M. Hagleitner, Birgit Burkhardt, Takeshi Mori, Andishe Attarbaschi, Jaime Verdú-Amorós, Marta Pillon, Liliya Anderzhanova, Edita Kabíčková, Alan K. S. Chiang, Rejin Kebudi, Karin Mellgren, Jelena Lazic, Janez Jazbec, Jules P. P. Meijerink, Auke Beishuizen, Jan L. C. Loeffen

    Published 2022-08-01
    Get full text
    Article
  13. 13
    Prognostic Factors in Childhood Anaplastic Large Cell Lymphoma: Long Term Results of the International ALCL99 Trial

    Prognostic Factors in Childhood Anaplastic Large Cell Lymphoma: Long Term Results of the International ALCL99 Trial by Lara Mussolin, Marié-Cecilé Le Deley, Elisa Carraro, Christine Damm-Welk, Andishe Attarbaschi, Denise Williams, Amos Burke, Keizo Horibe, Atsuko Nakazawa, Grazyna Wrobel, Georg Mann, Monika Csóka, Anne Uyttebroeck, Rafael Fernández-Delgado Cerdá, Auke Beishuizen, Karin Mellgren, Birgit Burkhardt, Wolfram Klapper, Suzanne D. Turner, Emanuele S.G. d’Amore, Laurence Lamant, Alfred Reiter, Wilhelm Woessmann, Laurence Brugières, Marta Pillon, on behalf of the European Inter-Group for Childhood Non-Hodgkin lymphoma (EICNHL)

    Published 2020-09-01
    Get full text
    Article
  14. 14
    Treatment and Outcome Analysis of 639 Relapsed Non-Hodgkin Lymphomas in Children and Adolescents and Resulting Treatment Recommendations

    Treatment and Outcome Analysis of 639 Relapsed Non-Hodgkin Lymphomas in Children and Adolescents and Resulting Treatment Recommendations by Birgit Burkhardt, Mary Taj, Nathalie Garnier, Veronique Minard-Colin, Volkan Hazar, Karin Mellgren, Tomoo Osumi, Alina Fedorova, Natalia Myakova, Jaime Verdu-Amoros, Mara Andres, Edita Kabickova, Andishe Attarbaschi, Alan Kwok Shing Chiang, Eva Bubanska, Svetlana Donska, Lisa Lyngsie Hjalgrim, Jacek Wachowiak, Anna Pieczonka, Anne Uyttebroeck, Jelena Lazic, Jan Loeffen, Jochen Buechner, Felix Niggli, Monika Csoka, Gergely Krivan, Julia Palma, G. A. Amos Burke, Auke Beishuizen, Kristin Koeppen, Stephanie Mueller, Heidi Herbrueggen, Wilhelm Woessmann, Martin Zimmermann, Adriana Balduzzi, Marta Pillon

    Published 2021-04-01
    Get full text
    Article

Search Tools: